Molecular Formula | C25H26Cl3N7O |
Molar Mass | 546.87924 |
Melting Point | 275-276℃ (decomposition) |
Solubility | DMSO 1 mg/mL heat Water <1 mg/mL Ethanol <1 mg/mL |
Appearance | powder |
Color | white to beige |
Storage Condition | room temp |
Use | A selective and high affinity CB1 antagonist. |
In vitro study | CP-945598 HCl inhibits the CB1 receptor with moderate unbound microsomal clearance, low hERG affinity, and adequate central nervous system penetration. CP-945598 HCl acts on the human CB2 receptor with a low affinity, K I of 7.6 μm. |
In vivo study | After CP-55940 treatment with synthetic CB1 receptor agonists, the CP-945598 of HCl reverses four cannabinoid agonist-mediated behaviors (spontaneous activity, hypothermia, analgesia, and general rigidity). CP-945598 HCl treated rodent models of acute food intake with loss of appetite and increased energy expenditure and fat oxidation. CP-945598 treatment of rats, severe stimulation of energy expenditure, and decreased the respiratory quotient, indicating metabolic conversion to increased fat oxidation. CP-945598 treated diet-induced obese mice at a dose of 10 mg/kg, CP-945598 promoted 9% weight loss in a 10-day weight loss study. |
WGK Germany | 3 |